Drug Product
Excipients & Specialty Ingredients
Company Overview
About
MarbleMat s.r.o. is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Quality Control, Stability Testing, Method Development
Therapeutic Areas
Neurology
Quick Facts
HQ:Czechia
Founded:2018
Employees:2,003
Capabilities & Services
Core Capabilities
- Cytotoxic / ADC Handling
- High-Potency API
- Sterile Fill/Finish
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Topical / Transdermal
Containment Capabilities
Cytotoxic / ADC Handling
Production Scales
Commercial Scale
Large Scale (Metric Ton+)
Markets Served
North America
Regulatory Approvals
Drug Approval OYK83D
Health Canada · #APR-L7SD1LN9 · 2022-01-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-T64JBEG9
Issued: 2020-12-07
Expires: 2025-01-01
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-07NYBUEV
Issued: 2020-03-16
Expires: 2025-11-07
WHO GMP
World Health Organization
Cert #: CERT-U75GKUWN
Issued: 2020-01-09
Expires: 2025-09-08
Loading CDMO intelligence...
Key facts about MarbleMat s.r.o.
- MarbleMat s.r.o. is headquartered in Czechia.
- MarbleMat s.r.o. was founded in 2018.
- MarbleMat s.r.o. has 2,003 employees.
- MarbleMat s.r.o.'s capabilities include Cytotoxic / ADC Handling, High-Potency API and Sterile Fill/Finish.
Find CDMOs like MarbleMat s.r.o.
Directory pages this company appears in, each with the full list of matching manufacturers.